Vision Screening for the Detection of Amblyopia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01430247 |
Recruitment Status :
Completed
First Posted : September 8, 2011
Last Update Posted : August 2, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
INTRODUCTION. Amblyopia is defined as the loss of visual acuity (VA) in one or both eyes, without any obvious structural or pathological anomalies. Amblyopic eye should be able to regain some VA if treatment is initiated before the age of seven. It is the leading cause of monocular blindness in the 20- to 70-year olds with prevalence 2-5%. Amblyopia is mainly monocular, hence children are general asymptomatic. VA testing is the only reliable method of detecting amblyopia, and the fourth year of life is considered best for vision screening programs.
AIM: The purpose of the study is to reduce the preventable vision loss. The main goal of the study is to evidence the problem of amblyopia in Zagreb and to release a model for formal, government directed vision-screening program as a Croatian public health policy.
HYPOTHESIS. In Croatia, the prevalence and actual effect of amblyopia and amblyogenic factors, along with treatment efficacy is impossible to quantify, since no population-based studies have been performed regarding this issue. In addition, national screening of preschool children does not exist, while the school-entry screening is prescribed by law. The object of the study is to determine the prevalence of amblyopia in a 4-4.5 year old children of The Town of Zagreb, the efficacy of screening and effectiveness of treatment on reducing amblyopia prevalence. The primary hypothesis is defined: screening of visual acuity monocularly at distance and near in 4-4.5 year old children in Zagreb is effective in detecting amblyopia.
PATIENTS AND METHODS: Monocular vision of about 7000 children/ year aged 4-4.5 for whom both parents gave consent is to be tested with Lea chart at near (40cm) and distance (3m) in the kindergartens of The Town of Zagreb. The criterion for referral to complete ophthalmological examination is VA <0.8.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Amblyopia Refractive Errors Anisometropia Strabismus Ptosis | Other: Amblyopia screening | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 7000 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Vision Screening of the Four Year Old Children for the Detection of Amblyopia in The Town of Zagreb |
Actual Study Start Date : | September 12, 2011 |
Actual Primary Completion Date : | September 12, 2014 |
Actual Study Completion Date : | September 12, 2014 |
Arm | Intervention/treatment |
---|---|
Amblyopia screening |
Other: Amblyopia screening
Monocular vision testing at near (40cm) and distance (3m) |
- prevalence of amblyopia [ Time Frame: 3 years ]proportion of children with amblyopia in a total population of children screened

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 48 Months to 54 Months (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- children in the kindergartens of The Town of Zagreb aged 4-4.5 for whom both parents gave written informed consent
Exclusion Criteria:
- children younger than 4 years and children older than 4.5 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01430247
Croatia | |
University Eye Clinic, University Hospital "Sveti Duh" | |
Zagreb, Croatia, 10 000 |
Principal Investigator: | Mladen Bušić | University Eye Clinic, University Hospital "Sveti Duh", Zagreb, Croatia |
Responsible Party: | Mladen Busic, Asst. prof., M.D., PhD, General Hospital Sveti Duh |
ClinicalTrials.gov Identifier: | NCT01430247 |
Other Study ID Numbers: |
30082011/2011 |
First Posted: | September 8, 2011 Key Record Dates |
Last Update Posted: | August 2, 2019 |
Last Verified: | July 2019 |
amblyopia amblyogenic factors screening |
preschool children visual acuity prevalence |
Amblyopia Strabismus Refractive Errors Anisometropia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Vision Disorders Sensation Disorders Neurologic Manifestations Eye Diseases Ocular Motility Disorders Cranial Nerve Diseases |